Combination Treatment of Human Pancreatic Cancer Xenograft Models with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib and Oncolytic Herpes Simplex Virus HF10
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination Treatment of Human Pancreatic Cancer Xenograft Models with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib and Oncolytic Herpes Simplex Virus HF10
Authors
Keywords
Pancreatic Cancer, Erlotinib, Interstitial Fluid Pressure, Combination Therapy Group, Dulbecco Modify Eagle Medium
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 21, Issue 2, Pages 691-698
Publisher
Springer Nature
Online
2013-10-30
DOI
10.1245/s10434-013-3329-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin
- (2013) Yuchen Fan et al. BIOMATERIALS
- Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer
- (2011) T T Sahin et al. CANCER GENE THERAPY
- A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer
- (2010) A Nakao et al. CANCER GENE THERAPY
- Impact of tumor microenvironment on oncolytic viral therapy
- (2010) Jeffrey Wojton et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
- (2010) Sonia Guedan et al. MOLECULAR THERAPY
- HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9
- (2009) Kozaburo Hayashi et al. ARCHIVES OF VIROLOGY
- VEGF-A expression by HSV-1–infected cells drives corneal lymphangiogenesis
- (2009) Todd R. Wuest et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1
- (2009) Jayson Hardcastle et al. MOLECULAR THERAPY
- Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
- (2008) C. R. Patra et al. CANCER RESEARCH
- Bevacizumab Increases Viral Distribution in Human Anaplastic Thyroid Carcinoma Xenografts and Enhances the Effects of E1A-Defective Adenovirus dl922-947
- (2008) S. Libertini et al. CLINICAL CANCER RESEARCH
- Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models
- (2008) S. Ganesh et al. CLINICAL CANCER RESEARCH
- Non-Engineered, Naturally Oncolytic Herpes Simplex Virus HSV1 HF-10:Applications for Cancer Gene Therapy
- (2008) Akihiro Nawa et al. CURRENT GENE THERAPY
- Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10
- (2008) Daisuke Watanabe et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61
- (2008) Kazuhiko Kurozumi et al. MOLECULAR THERAPY
- Bevacizumab and Erlotinib: A Promising New Approach to the Treatment of Advanced NSCLC
- (2008) R. S. Herbst et al. ONCOLOGIST
- Changes in pancreatic cancer mortality, period patterns, and birth cohort patterns in Japan: analysis of mortality data in the period 1968–2002
- (2008) Takayuki Seino et al. Environmental Health and Preventive Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now